TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.Published in:Journal of Pathology, 2019, v. 248, n. 3, p. 363, doi. 10.1002/path.5266By:Chen, Lin‐Yu;Huang, Rui‐Lan;Chan, Michael WY;Yan, Pearlly S;Huang, Tien‐Shuo;Wu, Ren‐Chin;Suryo Rahmanto, Yohan;Su, Po‐Hsuan;Weng, Yu‐Chun;Chou, Jian‐Liang;Chao, Tai‐Kuang;Wang, Yu‐Chi;Shih, Ie‐Ming;Lai, Hung‐ChengPublication type:Article